Published in J Clin Invest on February 01, 1995
Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev (2007) 6.53
MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A (2007) 3.97
Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest (2003) 1.73
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest (1996) 1.58
Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest (1996) 1.57
Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr (2012) 1.44
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest (1996) 1.41
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest (2016) 1.37
Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling. Diabetes (2012) 1.32
Concern Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice. J Physiol (2010) 1.15
Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes. J Clin Endocrinol Metab (2004) 1.08
Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care (2008) 1.02
Chronic consumption of a high-fat/high-fructose diet renders the liver incapable of net hepatic glucose uptake. Am J Physiol Endocrinol Metab (2010) 1.02
Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis. Diabetes (2011) 1.00
Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer. World J Gastroenterol (2010) 0.97
A high-fat, high-fructose diet accelerates nutrient absorption and impairs net hepatic glucose uptake in response to a mixed meal in partially pancreatectomized dogs. J Nutr (2011) 0.97
Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes (2011) 0.92
Exercise, hypoglycemia, and type 1 diabetes. Diabetes Technol Ther (2014) 0.91
Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia (2005) 0.90
Magnetic resonance spectroscopy studies of human metabolism. Diabetes (2011) 0.89
Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus. World J Diabetes (2014) 0.88
Hepatic steatosis in type 1 diabetes. Rev Diabet Stud (2012) 0.87
Butyrate ingestion improves hepatic glycogen storage in the re-fed rat. BMC Physiol (2008) 0.86
Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach. Am J Physiol Endocrinol Metab (2015) 0.85
Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Am J Physiol Endocrinol Metab (2014) 0.84
Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases. Exp Mol Med (2015) 0.82
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov (2016) 0.80
Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis. J Clin Invest (2016) 0.76
The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities. BMB Rep (2016) 0.76
Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments. Am J Physiol Endocrinol Metab (2015) 0.75
Insulin:Carbohydrate Ratio-Part of the Story. Diabetes Technol Ther (2015) 0.75
Prandial insulin and the systemic appearance of meal-derived glucose in people with type 1 diabetes. Diabetes Care (2008) 0.75
Noninvasive measurements of glycogen in perfused mouse livers using chemical exchange saturation transfer NMR and comparison to (13)C NMR spectroscopy. Anal Chem (2015) 0.75
Priming Effect of a Morning Meal on Hepatic Glucose Disposition Later in the Day. Diabetes (2017) 0.75
Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest (1992) 3.55
Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science (1991) 2.92
Selective population inversion in NMR. Nature (1984) 2.24
Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? J Biol Chem (1983) 2.22
Liver glycogen turnover in fed and fasted humans. Am J Physiol (1994) 1.57
Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. Am J Physiol (1990) 1.49
Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem (1993) 1.47
Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs. Diabetes (1976) 1.29
Quantitative analysis of glycogen repletion by nuclear magnetic resonance spectroscopy in the conscious rat. J Clin Invest (1987) 1.25
Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes (1974) 1.23
Effect of dietary protein on in vivo insulin action and liver glycogen repletion. Am J Physiol (1989) 1.21
Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes (1995) 1.16
Hypoglycemia in IDDM. Diabetes (1989) 1.15
Sources of carbon for hepatic glycogen synthesis in the conscious dog. J Clin Invest (1991) 1.15
Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes (1981) 1.09
Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes (1992) 1.07
Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol (1983) 1.06
Differential effect of hyperglycemia and hyperinsulinemia on pathways of hepatic glycogen repletion. Am J Physiol (1991) 0.88
Suppression of sleep-induced growth hormone secretion by anticholinergic agent abolishes dawn phenomenon. Diabetes (1988) 0.81
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (2001) 11.22
Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med (1999) 8.32
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia (1999) 8.17
Disruption of IRS-2 causes type 2 diabetes in mice. Nature (1998) 7.94
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell (2000) 7.26
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes (1999) 7.14
Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med (1990) 7.13
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature (2001) 6.70
Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest (1996) 6.50
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest (2002) 5.31
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell (2001) 5.13
Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes (2000) 4.80
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol (2000) 4.64
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med (1998) 4.40
Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest (1987) 4.26
Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem (2000) 3.90
Energy on demand. Science (1999) 3.80
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest (1992) 3.55
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab (2001) 3.45
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest (2000) 3.41
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A (1998) 3.17
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med (1996) 2.92
Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science (1991) 2.92
Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation (1997) 2.80
Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry (1999) 2.78
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes (1997) 2.76
Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest (2000) 2.75
Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest (2001) 2.68
31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 2.52
Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol (1999) 2.44
Spatially localized 1H NMR spectra of metabolites in the human brain. Proc Natl Acad Sci U S A (1988) 2.44
Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med (1994) 2.39
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes (1995) 2.30
Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1995) 2.25
13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes (1998) 2.21
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev (2001) 2.18
Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest (1997) 2.16
In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci U S A (1997) 2.12
Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes (2001) 2.10
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest (2001) 2.01
Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab (1995) 1.98
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 1.95
Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem (2000) 1.95
Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest (1987) 1.92
Improvements on an in vivo automatic shimming method [FASTERMAP]. Magn Reson Med (1997) 1.92
Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes (2000) 1.89
NMR determination of the TCA cycle rate and alpha-ketoglutarate/glutamate exchange rate in rat brain. J Cereb Blood Flow Metab (1992) 1.89
Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord (2003) 1.85
Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci U S A (1984) 1.76
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest (1998) 1.75
Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol (1999) 1.75
Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging. Proc Natl Acad Sci U S A (2001) 1.74
Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with 1H[13C]NMR. Proc Natl Acad Sci U S A (1996) 1.74
Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI. NMR Biomed (2001) 1.69
Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest (1995) 1.65
Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise. J Clin Endocrinol Metab (2000) 1.65
Dynamic shim updating: a new approach towards optimized whole brain shimming. Magn Reson Med (1996) 1.65
Echo-planar magnetic resonance imaging studies of frontal cortex activation during word generation in humans. Proc Natl Acad Sci U S A (1993) 1.60
Beta cell function during rapamycin monotherapy in long-term type 1 diabetes. Diabetologia (2010) 1.60
Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures. Neurology (2001) 1.60
Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J Neurochem (1994) 1.60
13C NMR of intermediary metabolism: implications for systemic physiology. Annu Rev Physiol (2001) 1.59
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest (1996) 1.58